No Data
No Data
Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating
Biogen (BIIB) has an average outperform rating and a price target range of $200 to $350, according to analysts polled by Capital IQ. Price: 218.82, Change: -0.10, Percent Change: -0.05
Eli Lilly Alzheimer's Therapy Set for June FDA AdCom Meeting
Biogen Is Maintained at Buy by HSBC
Biogen Is Maintained at Buy by HSBC
HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating
Biogen (BIIB) has an average outperform rating and a price target range of $200 to $350, according to analysts polled by Capital IQ. Price: 216.17, Change: +2.66, Percent Change: +1.25
No Data
Dramericanjesus : Tesla used a bullshit stock pump to keep it's stock price afloat after horrendous numbers. Some intern did a 5 minute mockup of a ride hailing service which will have a shitload of regulatory hurdles to overcome and is probably.no where near ready to deploy.
Shroomie Dramericanjesus: that's a ceo that I want in my portfolio
Gary Investz : almost fell asleep watching his video
EverDust : Elon Musk is willing to do anything to secure his 56b compensation package, by pumping up stocks with unrealistic expectations, even the executives left one by one. That one stock to stay away from.
MonkeyGee : at the end of the day, the news doesn't matter. The AI will move the stock in the direction with the least positions.